Drug-CoV: a drug-origin knowledge graph discovering drug repurposing targeting COVID-19

[1]  Kok Wai Wong,et al.  Modelling Multi-relations for Convolutional-based Knowledge Graph Embedding , 2022, KES.

[2]  Fan Zhang,et al.  GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing , 2022, BMC Bioinformatics.

[3]  M. Ghojazadeh,et al.  Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia: a systematic review and meta-analysis , 2022, Expert review of respiratory medicine.

[4]  Qingming Huang,et al.  Geometry Interaction Knowledge Graph Embeddings , 2022, AAAI.

[5]  Mitchell Joblin,et al.  Task-driven knowledge graph filtering improves prioritizing drugs for repurposing , 2022, BMC Bioinformatics.

[6]  Philip S. Yu,et al.  Deep learning for drug repurposing: Methods, databases, and applications , 2022, WIREs Computational Molecular Science.

[7]  Yonghwa Choi,et al.  BERN2: an advanced neural biomedical named entity recognition and normalization tool , 2022, Bioinform..

[8]  Cathy H. Wu,et al.  COVID-19 Knowledge Graph from semantic integration of biomedical literature and databases , 2021, Bioinform..

[9]  Q. Zhou,et al.  Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19 , 2021, J. Chem. Inf. Model..

[10]  C. Siu,et al.  Drug Repurposing for the Treatment of COVID‐19: A Knowledge Graph Approach , 2021, Advanced therapeutics.

[11]  Ji Liu,et al.  From distributed machine learning to federated learning: a survey , 2021, Knowledge and Information Systems.

[12]  R. Franco,et al.  Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19 , 2021, Clinical and translational medicine.

[13]  P. Lambin,et al.  Knowledge Graphs for COVID-19: An Exploratory Review of the Current Landscape , 2021, Journal of personalized medicine.

[14]  Xiaozhong Peng,et al.  A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome , 2021, Signal Transduction and Targeted Therapy.

[15]  Yuedong Yang,et al.  PharmKG: a dedicated knowledge graph benchmark for bomedical data mining , 2020, Briefings Bioinform..

[16]  Sairaj Satarker,et al.  JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy , 2020, Postgraduate medicine.

[17]  Marina Boudin Computational Approaches for Drug Repositioning: Towards a Holistic Perspective based on Knowledge Graphs , 2020, CIKM.

[18]  Rainer Gemulla,et al.  LibKGE - A knowledge graph embedding library for reproducible research , 2020, EMNLP.

[19]  Li Yang,et al.  COVID-19: immunopathogenesis and Immunotherapeutics , 2020, Signal Transduction and Targeted Therapy.

[20]  Boyan A. Onyshkevych,et al.  COVID-19 Literature Knowledge Graph Construction and Drug Repurposing Report Generation , 2020, NAACL.

[21]  B. Carleton,et al.  Does Ibuprofen Worsen COVID-19? , 2020, Drug Safety.

[22]  George Karypis,et al.  Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning , 2020, Journal of proteome research.

[23]  M. Pornour,et al.  JAK Inhibition as a New Treatment Strategy for Patients with COVID-19 , 2020, International Archives of Allergy and Immunology.

[24]  A. Spanevello,et al.  The pivotal link between ACE2 deficiency and SARS-CoV-2 infection , 2020, European Journal of Internal Medicine.

[25]  Martin Hofmann-Apitius,et al.  COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology , 2020, bioRxiv.

[26]  Theodore Dalamagas,et al.  BIP4COVID19: Releasing impact measures for articles relevant to COVID-19 , 2020, bioRxiv.

[27]  Russ B. Altman,et al.  A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases , 2019, bioRxiv.

[28]  Sameh K. Mohamed,et al.  Discovering protein drug targets using knowledge graph embeddings , 2019, Bioinform..

[29]  Ping Xuan,et al.  Convolutional Neural Network and Bidirectional Long Short-Term Memory-Based Method for Predicting Drug–Disease Associations , 2019, Cells.

[30]  Vít Novácek,et al.  Drug target discovery using knowledge graph embeddings , 2019, SAC.

[31]  L. mcauliffe,et al.  Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis , 2019, The Annals of pharmacotherapy.

[32]  Zhiyuan Liu,et al.  Graph Neural Networks: A Review of Methods and Applications , 2018, AI Open.

[33]  P. Sanseau,et al.  Drug repurposing: progress, challenges and recommendations , 2018, Nature Reviews Drug Discovery.

[34]  Jie Li,et al.  Review of Drug Repositioning Approaches and Resources , 2018, International journal of biological sciences.

[35]  Di Wu,et al.  DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.

[36]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[37]  George Papadatos,et al.  Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.

[38]  Pasquale Minervini,et al.  Convolutional 2D Knowledge Graph Embeddings , 2017, AAAI.

[39]  Sergey Plis,et al.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. , 2016, Molecular pharmaceutics.

[40]  Geoffrey E. Hinton,et al.  Deep Learning , 2015, Nature.

[41]  Markus Krötzsch,et al.  Wikidata , 2014, Commun. ACM.

[42]  Zhen Wang,et al.  Knowledge Graph Embedding by Translating on Hyperplanes , 2014, AAAI.

[43]  Ashwin Machanavajjhala,et al.  Network sampling , 2013, KDD.

[44]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[45]  A. Krogh What are artificial neural networks? , 2008, Nature Biotechnology.

[46]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[47]  C. Mattingly,et al.  The Comparative Toxicogenomics Database (CTD). , 2003, Environmental health perspectives.

[48]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.

[49]  Chao Che,et al.  Knowledge-Graph-Based Drug Repositioning against COVID-19 by Graph Convolutional Network with Attention Mechanism , 2021, Future Internet.